AVEO Pharmaceuticals Profit Margin

AVEO Pharmaceuticals (AVEO) currently reports a profit margin of -30.79% as of September 2022. That compares with -2.26% in the prior-year period — up 86.3% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore AVEO Pharmaceuticals's profit margin history and peer comparisons.

AVEO Pharmaceuticals's profit margin increased from -2.26% to -30.79% — a 86.3% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AVEO Pharmaceuticals's profit margin of -30.79% is lower than the Healthcare sector average of 15.58%. That is roughly 297.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but AVEO Pharmaceuticals's current -30.79% should be judged against Healthcare norms (sector average: 15.58%) and against AVEO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -30.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for AVEO Pharmaceuticals, and consider following AVEO for alerts when major investors trade the stock.